Masao Yukioka
Masao Yukioka publishes mostly in Rheumatology, Surgery and Pharmacology, on topics such as Rheumatoid Arthritis Research and Therapies, Musculoskeletal pain and rehabilitation and Spondyloarthritis Studies and Treatments.
- World rank
- #4,702,598 of 7,710,434 ranked researchers
- Rank in Japan
- #141,146 of 383,136
- Works
- 76
- Citations
- 2.3k
- Citations per work
- 30.7
What does Masao Yukioka research?
Masao Yukioka's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3849.5%
- Medicine3849.5%
- Everything else3646.9%
- Life Sciences33.6%
- 1Rheumatology26% of their works
- 2Surgery10% of their works
- 3Pharmacology7% of their works
- 4Physiology4% of their works
- 5Molecular Biology4% of their works
- 6Orthopedics and Sports Medicine4% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Musculoskeletal pain and rehabilitation
- Spondyloarthritis Studies and Treatments
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Systemic Lupus Erythematosus Research
- Autoimmune and Inflammatory Disorders Research
- Inflammatory mediators and NSAID effects
- Pain Mechanisms and Treatments
Which keywords describe Masao Yukioka's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Epidemiology, Psychological Factors and Chronic Pain.
- Neuropathic Pain
- Hemophagocytic Lymphohistiocytosis
- Cancer
- Fibromyalgia
- Antiphospholipid Syndrome
- Ankylosing Spondylitis
- Disability
- Chronic Pain
- Epidemiology
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Psychological Factors
- Central Sensitization
- Global Burden
- Spondyloarthritis
- Chronic Fatigue Syndrome
- Systemic Lupus Erythematosus
- Cyclooxygenase-2 Inhibitors
- Juvenile Idiopathic Arthritis
- Nociception
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Autoantibodies372 topics
- Cardiovascular Risk362 topics
- Inflammation362 topics
- Biological Therapy321 topic
- Rheumatoid Arthritis321 topic
- Epidemiology132 topics
- Psychological Factors132 topics
- Chronic Pain122 topics
- Central Sensitization92 topics
- Disability81 topic
- Global Burden81 topic
- Ankylosing Spondylitis61 topic
- Spondyloarthritis61 topic
- Antiphospholipid Syndrome51 topic
- Chronic Fatigue Syndrome51 topic
- Fibromyalgia51 topic
- Systemic Lupus Erythematosus51 topic
- Cancer41 topic
- Cyclooxygenase-2 Inhibitors41 topic
- Hemophagocytic Lymphohistiocytosis41 topic
- Juvenile Idiopathic Arthritis41 topic
- Neuropathic Pain41 topic
- Nociception41 topic
Where does Masao Yukioka work?
Masao Yukioka's main affiliation in the publication record is Yukioka Hospital, Japan.
How many publications and citations does Masao Yukioka have?
OpenAlex counts 76 works and 2,335 citations for Masao Yukioka, an h-index of 16, ranking #4,702,598 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Masao Yukioka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.